CMS Finalizes 2024 DIR Guidance, Launches PDE & Formulary Rules for CY 2026 (Week of 4/14/25–4/18/25)
Beacon Alert 2025-016 Weekly Regulatory Updates CMS continues its regulatory push toward greater transparency, drug pricing reform, and bid accuracy for Medicare Part D and Medicare Advantage. The April 14–18, 2025 updates provide critical directives for plan sponsors regarding Direct and Indirect Remuneration (DIR), Prescription Drug Event (PDE) data reporting, 2026 formulary submissions, and Medicare […]